New CEO at BioCeramic Therapeutics
This article was originally published in Scrip
BioCeramic Therapeutics, a UK company focused on the field of biomaterials for healthcare, has named Ian Brown chief executive officer. The appointment is part of a succession plan that was developed by the company's board of directors over the past six months for its CEO position, which will see Daniel Green, BioCeramic's outgoing founding CEO, remain as a director. Mr Brown has previously held senior executive positions at Chromogenix, Instrumentation Laboratory, Cordlife, SDP Technology and Avanti Capital.
You may also be interested in...
Hiring travails, inspection pre-announcement, lack of translators highlighted in congressional hearing on FDA foreign inspections.
The court included its decision on Amarin’s ’s petition for a writ of certiorari among the single-line denials of nearly 200 appeals to consider decisions in civil litigation and convictions in criminal cases. However, Amarin still eyes curbing competition from omega-3 supplements.
Senate's Over-the-Counter Monograph Safety, Innovation, and Reform Act goes next for consideration by House, which has had a bill by the same title on its floor for a vote since it was passed by Energy and Commerce Committee in late June.